(S1 (S (NP (DT The) (NNP Food) (CC and) (NNP Drug) (NNP Administration)) (VP (VBD said) (SBAR (S (NP (NNP American) (NNP Home) (NNPS Products) (NNP Corp.)) (VP (VBD agreed) (S (VP (TO to) (VP (VB recall) (NP (NP (JJ certain) (JJ generic) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (VP (VBN produced) (PP (IN by) (NP (PRP$ its) (NNP Quantum) (NNP Pharmics) (NN unit))) (PP (IN in) (NP (NP (NNP Amityville)) (, ,) (NP (NNP N.Y)))))))))))))))) (. .)))

(S1 (S (NP (NNP Quantum)) (VP (VBD stopped) (S (VP (VBG shipping) (NP (DT the) (NNS drugs)) (NP (JJ last) (NN month)))) (, ,) (PP (VBG following) (NP (NP (DT a) (JJ federal) (NN investigation)) (VP (VBG regarding) (NP (NP (NN information)) (SBAR (S (NP (DT the) (NN company)) (VP (VBD supplied) (S (VP (TO to) (VP (VB obtain) (NP (CD three) (NN drug) (NNS approvals))))))))))))) (. .)))

(S1 (S (NP (DT The) (NNP FDA)) (VP (VBD requested) (NP (NP (DT the) (NN recall)) (PP (IN of) (NP (NP (NP (NNP Quantum) (POS 's)) (NN mioxidil) (NNS tablets)) (, ,) (NP (JJ chlorazepate) (NN dipotassium) (NNS tablets)) (CC and) (NP (JJ meclofenamate) (NN sodium) (NNS capsules))))) (SBAR (IN because) (S (PRN (, ,) (NP (PRP it)) (VP (VBD said)) (, ,)) (NP (NP (DT the) (NN size)) (PP (IN of) (NP (DT the) (NN production)))) (VP (VBZ runs) (VP (VBN submitted) (PP (IN for) (NP (NN testing))) (S (VP (TO to) (VP (VB gain) (NP (NNP FDA) (NN approval) (S (VP (VBD was) (PP (IN in) (NP (NP (DT each) (NN case)) (VP (VBD misrepresented) (PP (IN as) (ADJP (ADJP (RB much) (JJR larger)) (SBAR (IN than) (S (NP (PRP it)) (ADVP (RB actually)) (VP (VBD was)))))))))))))))))))) (. .)))

(S1 (S (NP (NP (NNP American) (NNP Home) (NNPS Products)) (, ,) (VP (VBN based) (PP (IN in) (NP (NNP New) (NNP York)))) (, ,)) (VP (VBD agreed) (S (VP (TO to) (VP (VB recall) (NP (NP (CD four) (JJ other) (NNS products)) (, ,) (ADJP (JJ trazadone) (, ,) (JJ doxepin) (, ,) (JJ diazepam) (CC and) (JJ lorazapam)) (, ,)) (PP (IN because) (IN of) (NP (NP (NNS concerns)) (PP (IN about) (NP (NP (NNS data)) (VP (VBN submitted) (PP (IN in) (NP (NP (PRP$ their) (JJ original) (NN approval) (NNS applications)) (PP (IN before) (NP (DT the) (NNP FDA)))))))))))))) (. .)))

(S1 (S (S (NP (NP (DT No) (NN safety) (NNS problems)) (PP (IN with) (NP (DT the) (NNS products)))) (VP (VBP are) (VP (VBN known)))) (, ,) (NP (DT the) (NNP FDA)) (VP (VBD said)) (. .)))

(S1 (S (NP (DT An) (NNP FDA) (NN spokesperson)) (VP (VBD said) (SBAR (S (NP (DT the) (NNS drugs)) (VP (VBP are) (ADVP (RB still)) (ADJP (JJ available)) (PP (IN under) (NP (JJ other) (NN brand) (NNS names))))))) (. .)))

(S1 (S (NP (JJ Last) (NN month)) (, ,) (NP (NNP American) (NNP Home) (NNPS Products)) (VP (VBD said) (SBAR (S (NP (PRP it)) (VP (VBD was) (VP (VBG suspending) (NP (NP (NN production) (CC and) (NN distribution)) (PP (IN of) (NP (NP (DT all) (CD 21)) (PP (IN of) (NP (NP (NP (NNP Quantum) (POS 's)) (JJ generic) (NN drug) (NNS products)) (PP (VBG pending) (NP (NP (DT the) (NN completion)) (PP (IN of) (NP (DT an) (JJ exhaustive) (JJ internal) (NN audit))))))))))))))) (. .)))

(S1 (S (NP (PRP It)) (ADVP (RB also)) (ADVP (RB temporarily)) (VP (VBD closed) (NP (NNP Quantum)) (, ,) (PP (IN because) (IN of) (NP (NP (DT the) (JJ internal) (NN investigation)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT the) (NNP FDA) (POS 's)) (JJ ongoing) (NN inquiry))))) (. .)))

(S1 (S (PP (IN In) (NP (NNP New) (NNP York) (NNP Stock) (NNP Exchange) (JJ composite) (NN trading))) (, ,) (NP (NNP American) (NNP Home) (NNPS Products)) (VP (VBD rose) (NP (CD 75) (NNS cents)) (PP (TO to) (NP ($ $) (CD 105))) (PP (IN on) (NP (NNP Friday)))) (. .)))

